In pancreatic cancer, ANLN depletion downregulates multiple cell-adhesion-related genes, particularly LIM and SH3 domain protein 1(LASP1), thereby impairing migration, invasion, and tumorigenic capacity (Wu et al., 2024). The gene discussed is ANLN; the disease is pancreatic neoplasm.